CHD | |||||
---|---|---|---|---|---|
 | B2M | ORM1 | THBS1 | CFD | IGFBP1 |
Baseline biomarker | 1.21 (1.09, 1.35)a,c | 1.01 (0.89, 1.14) | 0.97 (0.93, 1.00) | 1.16 (1.03, 1.31)c | 1.03 (0.99, 1.08) |
Treatmentb | 1.32 (0.97, 1.81) | 1.33 (0.97, 1.81) | 1.34 (0.96, 1.87) | 1.31 (0.95, 1.78) | 1.29 (0.94, 1.77) |
Trialb | 1.13 (0.82, 1.56) | 1.09 (0.79, 1.51) | 1.02 (0.72, 1.44) | 1.09 (0.79, 1.50) | 1.05 (0.76, 1.47) |
Stroke | |||||
 | B2M | IGFBP2 | IGFBP4 | IGFBP6 | HPX |
Baseline biomarker | 1.18 (1.04, 1.34)a,c | 1.10 (1.03, 1.18)c | 1.16 (1.04, 1.28)c | 1.01 (0.94, 1.09) | 1.10 (0.95, 1.27) |
Treatmentb | 1.90 (1.38, 2.62) | 1.77 (1.27, 2.46) | 1.76 (1.21, 2.54) | 1.70 (1.22, 2.38) | 1.79 (1.30, 2.48) |
Trialb | 1.09 (0.79, 1.50) | 1.10 (0.79, 1.53) | 1.09 (0.75, 1.59) | 1.11 (0.79, 1.55) | 1.13 (0.81, 1.56) |